Skip to content

Public FDA record

Z-0073-2007: HYDRAGEL 15 Alkaline Hemoglobin (E) kit, in vitro diagnostic, Sebia Parc Technologique Leonard de Vinci,

Recall record Z-0073-2007 for Sebia, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0073-2007
Company in FDA record
Sebia, Inc.
FDA classification date
Oct 25, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The material used in packaging the product results in the presence of an additional artifact band above the HbA fraction.

Source facts

Action
Consignees were notified via fax letter and also by phone contact on or about 08/29/2006.
Initiated
2006-08-29
Root cause
Other
Terminated
2010-01-28
Distribution
Nationwide (AL, CA, CO, FL, GA, IL, KA, LA, MD, MI, NM, NC, NJ, NY, PA, TX, VA, WI) and Puerto Rico
Recall number
Z-0073-2007
Recall status
Terminated
CDRH record ID
48611
FDA classified
2006-10-25
Recall event number
36413

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗